Article info
Clinical science
Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome
- Correspondence to Dr Assaf Dotan, Department of Ophthalmology, Rabin Medical Center, Beilinson Campus, Petach Tikva 49100, Israel; docdotan{at}gmail.com
Citation
Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome
Publication history
- Received September 5, 2013
- Revised October 22, 2013
- Accepted November 3, 2013
- First published November 25, 2013.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions